Salute e Benessere

AB Science will participate in the Biomed Forum investors conference

PRESS RELEASEAB SCIENCE WILL PARTICIPATE IN THE BIOMED FORUM INVESTORS CONFERENCEParis, 22 january 2024, 7pm CETAB Science SA(Euronext – FR0010557264 – AB) announced that its management team will participate in the upcoming edition of the Biomed Forum, a conference for institutional investors. Organized by AllInvest Securities, this event will take place on February 4, 2025, in Paris. About AB ScienceFounded in 2001, AB Science is a pharmaceutical company specializing in the...
Nasdaq GlobeNewswire
22/01/2025

Spineway : 2024 revenue of €12 million - 14% growth compared with 2023

Press release Ecully, January 22, 2025 – 6.30 p.m. SPINEWAY 2024 revenue of €12 million14% growth compared with 2023In thousands of euros 20242023Change as a %H1 revenue6,5355,431+20%H2 revenue5,4155,088+6% Full-year revenue11,95010,519+14%Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, is reporting annual revenue of €11...
Nasdaq GlobeNewswire
22/01/2025

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine…

Saint-Herblain (France), January 22, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its single-shot chikungunya vaccine, IXCHIQ ®, in 304 children. Partially funded by the Coalition for Epidemic Preparedness Innovations (CEPI), with support from the European Union, the trial is intended to support a pivotal Phase 3 study in children, which the...
Nasdaq GlobeNewswire
22/01/2025

Swiss startup Risklick launches AI-based software for medical device clinical…

Bringing a medical device to market typically takes 3 to 7 years, with clinical investigations being the most time-consuming and costly phase. Every clinical trial begins with the development of a protocol, which serves as the cornerstone of the study and determines the trial's success or failure. Developing a protocol requires an average of six months of intensive work, where even minor errors can result in serious consequences for the clinical trial. Bringing a medical device to market...
PR Newswire
22/01/2025

deCODE genetics: Complete recombination map of the human-genome, a major step in…

While this shuffling, known as recombination, is essential for genetic diversity, errors in the process can lead to serious reproductive issues. These failures can result in genetic errors that prevent pregnancies from continuing, helping to explain why infertility affects around one in ten couples worldwide. Understanding this process offers new hope for improving fertility treatments and diagnosing pregnancy complications. While this shuffling, known as recombination, is essential for…
PR Newswire
22/01/2025

Forum 30: Advancing Global Standards for Medical Products of Human Origin

Discussions also emphasized technical interoperability to ensure safe management of MPHO and the need to address challenges through global regulatory alignment. Experience was shared of investigations of MPHO-related adverse events and how harm to recipients and healthcare professionals could be minimized. Discussions also emphasized technical interoperability to ensure safe management of MPHO and the need to address challenges through global regulatory alignment. Experience was shared of...
PR Newswire
22/01/2025

Bunion Surgery Market worth $606.1 million by 2029 with 5.7% CAGR |…

Browse in-depth TOC on "Bunion Surgery Market" Browse in-depth TOC on "Bunion Surgery Market" 240 - Tables 49 - Figures 234 - Pages By product,the bunion surgery market is segmented into correction systems and implants & accessories. The largest share of bunion surgery market was held by the implants & accessories segment in 2023. With an increased prevalence of bunions, more patients are opting for surgical treatment, which, in most cases, comprises the use of...
PR Newswire
22/01/2025

Natural Adhesion Barrier Market to Reach USD 1.15 Billion by 2031, Driven by…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1019820 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1019820 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Natural Adhesion Barrier Market Overview Market Definition and Scope The Natural Adhesion Barrier Market focuses on products designed to prevent post-surgical adhesions using naturally derived materials like hyaluronic acid,...
PR Newswire
22/01/2025

Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR |…

Browse in-depth TOC on "Oligonucleotide CDMO Market" Browse in-depth TOC on "Oligonucleotide CDMO Market" 270 - Tables56 - Figures254 - Pages Based on the service types,the global oligonucleotide CDMO market is divided into contract development, contract manufacturing, and other services. The contract manufacturing segment is expected to dominate the oligonucleotide CDMO market, fueled by the increasing need for large-scale, cGMP-compliant production of oligonucleotide...
PR Newswire
22/01/2025

Medical Device Connectivity Market is expected to generate a revenue of USD 13.4…

Key Highlights of the Report: Key Highlights of the Report : Who Should Read This Report? This report is an essential resource for: Stay ahead of the curve in the ever-evolvingMedical Device Connectivity Market. For more information or to request a sample copy of the report, please visit:https://www.verifiedmarketresearch.com/download-sample/?rid=1909 Browse in-depth TOCon" Global Medical Device Connectivity Market Size " 202 - Pages 126 – Tables 37 –...
PR Newswire
22/01/2025

Veterinary Vaccines Market to Hit US$13.33 Billion by 2029 with 6.1% CAGR |…

Browse in-depth TOC on "Veterinary Vaccines Market"451 - Tables67 - Figures406 - Pages Browse in-depth TOC on "Veterinary Vaccines Market" 451 - Tables 67 - Figures 406 - Pages Based on type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines, and other animal vaccines. In 2023, the livestock vaccines segment accounted for the largest share. Livestock animals are owned to...
PR Newswire
22/01/2025

TraceLink Named to the 2025 RXinsider Pharmacy500 List for Excellence in…

"As regulations like the Drug Supply Chain Security Act (DSCSA) reshape the industry, our focus remains on empowering our customers with transformative solutions that ensure compliance, enhance safety, and drive operational excellence," said Shabbir Dahod, President and CEO of TraceLink. "This recognition reflects the trust that our growing digital network community places in TraceLink to help navigate the complexities of the modern supply chain while delivering impactful results…
PR Newswire
22/01/2025

Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers…

VANCOUVER, BC, Jan. 22, 2025 /PRNewswire/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCOGastrointestinal Cancers Symposium, running January 23-25 in San Francisco. This year's event is particularly critical as researchers highlight the alarming rise in cancer rates among people under 50, with gastrointestinal cancers leading the increase. Colorectal and pancreatic cancers, two of the top three deadliest cancer types, remain significant concerns as…
PR Newswire
22/01/2025

Nomination Committee's proposal for Board of Directors of AB SKF

The Nomination Committee, furthermore, in addition to the proposed new election of Mats Rahmström, proposes re-election of the board members Hans Stråberg, Hock Goh, Geert Follens, Håkan Buskhe, Susanna Schneeberger, Rickard Gustafson, Beth Ferreira, Therese Friberg, Richard Nilsson and Niko Pakalén. The Nomination Committee, furthermore, in addition to the proposed new election of Mats Rahmström, proposes re-election of the board members Hans Stråberg, Hock Goh,Geert Follens, Håkan Buskhe,...
PR Newswire
22/01/2025

OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding

LONDON and NEW YORK, Jan.22, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, is pleased to announce that it has received $1.4 million in non-dilutive funding. This significant financial funding strengthens the Company's...
Nasdaq GlobeNewswire
22/01/2025

Ultrasound Market worth $13.87 billion in 2030 with 6.8% CAGR |…

Browse in-depth TOC on "Ultrasound Market" Browse in-depth TOC on "Ultrasound Market" 478 - Tables 57 - Figures 419 - Pages By display,Color ultrasound segment to command the highest growth rate during the study period. Color ultrasound shows the maximum growth rate in the market for ultrasound as it can easily produce high-resolution, real-time images to improve diagnostic efficacy for diverse applications. As the equipment can be fitted with Doppler technology, thus...
PR Newswire
22/01/2025

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

Company Announcement Net sales of DARZALEX ®in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)COPENHAGEN, Denmark; January 22, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj , sold under the tradename DARZALEX...
Nasdaq GlobeNewswire
22/01/2025

The First "AI Hyperspectral Optical Sorter for Blended Fabrics" in China…

Technological Breakthrough: Empowering the Development of Textile RecyclingThe "AI-powered hyperspectral sorter for blended fabrics" revolutionizes the technology for sorting mixed textiles: Technological Breakthrough: Empowering the Development of Textile RecyclingThe "AI-powered hyperspectral sorter for blended fabrics" revolutionizes the technology for sorting mixed textiles: Leading a New Chapter in Blended Fabric SortingAfter seven years of dedicated development…
PR Newswire
22/01/2025

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4…

T uesday, 4 February 2025 at 11.00 - 12.00am CET(corrected from 10.00 - 11.00am CET in an earlier version of this invitation)In connection with the publication of Coloplast's interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference...
Nasdaq GlobeNewswire
22/01/2025

HR organisations brace for leadership exodus in Europe fuelled by rising stress…

Eighty percent of HR organisations in Europe are predicting a surge in the need for new leadership capabilities in the next five years. However, only 22% of HR organisations have prioritised addressing the top four most critical skill gaps within current development plans. Eighty percent of HR organisations inEuropeare predicting a surge in the need for new leadership capabilities in the next five years. However, only 22% of HR organisations have prioritised addressing the top four most...
PR Newswire
22/01/2025

Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing

"This funding represents a critical milestone in our journey to address significant unmet medical needs, from familial forms of dementia and Alzheimer's to novel treatments for inflammatory skin diseases. The new investors bring expertise and strategic value to the table, enabling us to accelerate the development of groundbreaking treatments," said Ivar Hakonarson, ATx co-founder and CEO. "This funding represents a critical milestone in our journey to address significant unmet…
PR Newswire
22/01/2025

Essity ranked one of the world's most sustainable companies

"We are pleased to once again be recognized as one of the world's most sustainable companies by Corporate Knights. Essity's commitment to improving hygiene and health while responsibly managing our climate and environmental footprint continues, we strive for continuous improvement and never settle for less," says Sahil Tesfu, Chief Strategy and Sustainability Officer, Essity. "We are pleased to once again be recognized as one of the world's most sustainable companies by Corporate…
PR Newswire
22/01/2025

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital…

"Technological advancements and the recent surge in AI have reshaped the future of healthcare, enabling the extraction of valuable insights that will have real benefits for patients," shared Dr. Lin. "3D pathology can offer at least 50 times more information than conventional 2D methods, providing pathologists with a more comprehensive understanding of a tumor's biology. The power of such a diagnostic tool lies in its ability to help pathologists stratify and personalize, matching…
PR Newswire
22/01/2025

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in…

Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myelomaApproval is based on positive results from the IMROZ phase 3 study, demonstrating Sarclisa in combination with standard-of-care treatment significantly improved PFS, compared to the standard of care alone in TI NDMMRepresents third indication in the EU, including two for the treatment of adult patients with R/R MM, and one in...
Nasdaq GlobeNewswire
22/01/2025
Altri  Comunicati